Menu
Amprion attends the world’s leading neuroscience conferences, symposiums, and summits.
Amprion connects with breakthrough-seeking medical and research professionals to crack the code on precision medicine for Alzheimer’s, Parkinson’s, Lewy Body Dementia, and other neurodegenerative diseases through early detection. We look forward to meeting you!
April 22-27, 2023 | Boston
July 16-20, 2023 | Amsterdam
Aug 27-31, 2023 | Copenhagen
A pioneer in the science of detecting mis-folded proteins, Amprion advances the diagnosis of brain disorders. Our SYNTap™️ Biomarker Test aids physicians in diagnosing Parkinson’s, Lewy Body Dementia, and Alzheimer’s with Lewy Body variant. We plan to launch more biomarker tests in the future.
Amprion has some important news we need to share with you!
To improve patient access to the SYNTap® biomarker test (CSF), Amprion is reducing the self-pay price for tests with service dates on or after July 1, 2023.
Old self-pay price: $1500.00. New self-pay price: $995.00
Effective July 1, 2023, there is a New ABN (Advanced Beneficiary Notification) form for use when ordering the SYNTap® biomarker test (CSF) for patients on Medicare. Order Process
